Cargando…
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
Plasma concentrations, after administration of varying doses of nicotinamide, were measured in CBA male mice using a newly-developed high performance liquid chromatography assay. In all dose groups, peak levels were observed within the first 15 min after an i.p. administration of 0.1, 0.2, 0.3 or 0....
Autores principales: | Rojas, A., Hodgkiss, R. J., Stratford, M. R., Dennis, M. F., Johns, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968644/ https://www.ncbi.nlm.nih.gov/pubmed/8260362 |
Ejemplares similares
-
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
por: Hoskin, P. J., et al.
Publicado: (1997) -
Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
por: Laurence, V. M., et al.
Publicado: (1995) -
The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
por: Fenton, B. M.
Publicado: (1995) -
Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels
por: Robinson, S P, et al.
Publicado: (2000) -
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
por: Chaplin, D. J., et al.
Publicado: (1993)